Ioana I Braicu

8PUBLICATIONS
76CO-AUTHORS
Molecular targetsPredictive and prognostic markersMajor global burdens of diseaseSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 02, 2026
Spatial, temporal, and molecular heterogeneity of ADC targets in high-grade serous ovarian carcinoma.

|Jul 15, 2025
Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer.

Sofya Marchenko, Niklas Goernitz, Wiebke A Zoern

|May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium.

Nicole Concin, Ioana Braicu, Pierre Combe

|May 13, 2025
Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD)-European Society of Gynaecologic Oncology (ESGO)-Gynecologic Cancer InterGroup (GCIG)-International Society for the Study of Trophoblastic Diseases (ISSTD).

Christianne Lok, Nienke van Trommel, Elena Ioana Braicu

|Apr 19, 2025
Transforming treatment paradigms: Focus on personalized medicine for high-grade serous ovarian cancer.

Pawel Kordowitzki, Britta Lange, Kevin M Elias

|Nov 26, 2024
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.

Christian Marth, Richard G Moore, Mariusz Bidziński

Pageof 2

Frequent Collaborators

4 joint publications

Jalid Sehouli

3 joint publications

Wolfgang D Schmitt

3 joint publications

David Horst

2 joint publications

Eliane T Taube